Follow the people · Insider
Abhimanyu Verma
Abhimanyu Verma files insider transactions with the SEC as a chief technology officer of SOPHiA GENETICS SA (SOPH). We hold 8 disclosed purchases and sales filed since 3 April 2026, 6 of them in the last 90 days.
- Files forSOPH
- Disclosed buys and sells8 in all, 6 in the last 90 days
- Last disclosure26 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 2 April 2026 — 24 August 2026Chief Technology Officer · SOPHiA GENETICS SA (SOPH)12 Form 4 lines · source: SEC Form 4
Everything they disclosed
12 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 5,000 shares of SOPHiA GENETICS SASEC Form 426 August 2026Ordinary Shares · traded 19 August 2026 · filed 26 August 2026
- ▼ sold on the open market 5,000 shares of SOPHiA GENETICS SASEC Form 426 August 2026Ordinary Shares · traded 24 August 2026 · filed 26 August 2026
- ▼ sold on the open market 5,000 shares of SOPHiA GENETICS SASEC Form 410 August 2026Ordinary Shares · traded 7 August 2026 · filed 10 August 2026
- ▼ sold on the open market 5,000 shares of SOPHiA GENETICS SASEC Form 45 August 2026Ordinary Shares · traded 4 August 2026 · filed 5 August 2026
- ▼ sold on the open market 5,285 shares of SOPHiA GENETICS SASEC Form 47 July 2026Ordinary Shares · traded 6 July 2026 · filed 7 July 2026
- ▼ sold on the open market 6,944 shares of SOPHiA GENETICS SASEC Form 426 June 2026Ordinary Shares · traded 25 June 2026 · filed 26 June 2026
- was granted 82,136 shares of SOPHiA GENETICS SASEC Form 48 April 2026Ordinary Shares · traded 2 April 2026 · filed 8 April 2026
- was granted 119,760 shares of SOPHiA GENETICS SA (a derivative holding)SEC Form 48 April 2026Share Option (Right to Buy) · traded 2 April 2026 · filed 8 April 2026
- ▼ sold on the open market 2,519 shares of SOPHiA GENETICS SASEC Form 48 April 2026Ordinary Shares · traded 6 April 2026 · filed 8 April 2026
- ▼ sold on the open market 1,030 shares of SOPHiA GENETICS SASEC Form 48 April 2026Ordinary Shares · traded 7 April 2026 · filed 8 April 2026
- was granted 82,136 shares of SOPHiA GENETICS SASEC Form 43 April 2026Ordinary Shares · traded 2 April 2026 · filed 3 April 2026
- was granted 119,760 shares of SOPHiA GENETICS SA (a derivative holding)SEC Form 43 April 2026Share Option (Right to Buy) · traded 2 April 2026 · filed 3 April 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.